Connection

Paolo Maggi to HIV-Associated Lipodystrophy Syndrome

Back to Details
This is a "connection" page, showing publications Paolo Maggi has written about HIV-Associated Lipodystrophy Syndrome.
Paolo Maggi
Connection Strength
0.191
HIV-Associated Lipodystrophy Syndrome
  1. Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). BMC Infect Dis. 2018 07 31; 18(1):357.
    View in: PubMed
    Score: 0.191
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.